Willemijn F. Rijnink

SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2

Fatima Amanat, Mahima Thapa, Tinting Lei et al. · Cell · 2021 · 305 citations · Full text

Vaccination, Diverse Antibodies, Vaccine Development +6

Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses

Norbert Pardi, Juan Manuel Carreño, George O’Dell et al. · Nature Communications · 2022 · 82 citations · Full text

Engineering, Immunology, Influenza B Viruses +16

Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses

Meagan McMahon, George O’Dell, Jessica Tan et al. · Proceedings of the National Academy of Sciences · 2022 · 77 citations · Full text

Vaccination, Cross-protection, Group 2 +15

The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD

Fatima Amanat, Mahima Thapa, Tinting Lei et al. · 2021 · 44 citations · Full text

Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses

Willemijn F. Rijnink, Daniel Stadlbauer, Eduard Puente‐Massaguer et al. · Journal of Virology · 2023 · 14 citations · Full text

Vaccination, Influenza A Viruses, Cross-protection +15